Brightseed

About:

Brightseed uses artificial intelligence and machine learning to discover the potential of plant compounds for various applications.

Website: https://brightseedbio.com

Twitter/X: BrightseedBio

Top Investors: AgFunder, Bill & Melinda Gates Foundation, Fifty Years, S2G Ventures, Temasek Holdings

Description:

Brightseed is a pioneer in biosciences and artificial intelligence that illuminates nature to restore human health. Through Forager® A.I. and clinical evaluation, Brightseed helps companies gain the deepest insight into bioactives and their innovation potential. Forager A.I. accelerates bioactive discovery and biological validation from years to months – and is rapidly revealing new connections between nature and humanity. Brightseed partners with companies across the consumer health continuum to provide novel insights and science-backed health solutions. Bioactives are small molecule compounds produced by plants, fungi, and microbes that grow in and adapt to environments that present a wide range of challenges to their survival. Bioactives also benefit the health of humans – they are the enlivening caffeine in tea, the powerful antioxidant lycopene in tomatoes, and they inform active ingredients in medicines like Taxol, Aspirin, and Metformin, a first-line treatment for Type 2 diabetes, derived from the French lilac flower. Science has long known that bioactives are critical to human health, yet the vast majority remain unknown and uncharted. Brightseed’s A.I., Forager®, discovers bioactives in nature and maps them to human health outcomes at a rate and accuracy that was previously impossible.

Total Funding Amount:

$121M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)brightseedbio.com

Founders:

Jim Flatt, Lee Chae, Sofia Elizondo

Number of Employees:

51-100

Last Funding Date:

2023-12-19

IPO Status:

Private

© 2024 MyAiNote.com